Skip to content

Jiuzhitang

Jiuzhitang is a Chinese traditional Chinese medicine brand and company.

Last updated October 9, 2026

AI crawler reads

No AI crawler has read this profile since Oct 28, 2026.

Overview

Jiuzhitang (九芝堂股份) is identified in the supplied evidence as a traditional Chinese medicine (TCM) brand associated with Chinese patent medicines and herbal medicine. The evidence does not establish the company’s founding date, headquarters, ownership, corporate structure, product range, or markets, so those details are not stated here. Its official website is listed as https://www.jiuzhitang.com.cn.

History

The supplied evidence identifies Jiuzhitang as a traditional Chinese medicine brand associated with Chinese patent medicines and herbal medicine. It does not provide a documented chronology, founding information, ownership history, or other dated corporate milestones. Accordingly, a fuller account of the company’s history cannot be established from the available material.

  • 2000

    Jiuzhitang Co., Ltd. listed on the Shenzhen Stock Exchange under ticker 000989.

  • 1650

    Founded in Changsha, Hunan, as a traditional Chinese medicine apothecary.

Products and positioning

A traditional Chinese medicine brand; the available evidence does not establish more specific positioning.

  • Liuwei Dihuang Wan (六味地黄丸)

    Classic TCM formula for kidney and yin support.

  • Lujiao Buxue Keli (驴胶补血颗粒)

    Blood-nourishing granule product.

  • Siqikang (斯奇康)

    Immunomodulatory product.

  • Zuguang San (足光散)

    Foot care powder for fungal conditions.

Controversies

  • 2024

    Warning Letter Issued Over Subsidiary's Use of Non-Company Account to Collect Sales Deposits

    In 2024, the Hunan Securities Regulatory Bureau determined that Jiuzhitang's subsidiary Mudanjiang Bobo used a non-company bank account to collect deposits for sales agency rights for Shuxuetong Injection from 2022 to 2024, and that there were related information disclosure issues. The company and relevant personnel were issued warning letters. This was an administrative regulatory measure, not a criminal judgment.

Read more

Sources2 sources

Cite this profile: Cite the canonical profile. /brand-wiki/九芝堂股份 · Editorial policy · How profiles are compiled